Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-03
DOI
10.1038/s41598-019-42069-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement
- (2017) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality of life, long-term survivors and long-term outcome from the ABC-02 study
- (2016) John Bridgewater et al. BRITISH JOURNAL OF CANCER
- Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance
- (2016) Daniel H. Ahn et al. CANCER
- Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
- (2016) Michael Stotz et al. PLoS One
- Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
- (2016) Christian Mayr et al. Biomed Research International
- Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues
- (2015) Bertrand Brieau et al. CANCER
- Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease
- (2015) Angela Lamarca et al. EUROPEAN JOURNAL OF CANCER
- FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients
- (2015) Chandragouda Dodagoudar et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
- (2015) Lorenzo Fornaro et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma
- (2015) Joannis Panotopoulos et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
- (2015) Jean-Florian Guion-Dusserre et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
- (2015) Christian Mayr et al. Oncotarget
- Second-line chemotherapy in advanced biliary cancer: a systematic review
- (2014) A. Lamarca et al. ANNALS OF ONCOLOGY
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
- (2013) J. W. Valle et al. ANNALS OF ONCOLOGY
- Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
- (2013) J Szkandera et al. BRITISH JOURNAL OF CANCER
- The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
- (2013) Peter C. Austin STATISTICS IN MEDICINE
- Classification, Diagnosis, and Management of Cholangiocarcinoma
- (2012) Nataliya Razumilava et al. Clinical Gastroenterology and Hepatology
- Outcome of second-line chemotherapy for biliary tract cancer
- (2012) John Bridgewater et al. EUROPEAN JOURNAL OF CANCER
- Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
- (2012) Thomas Walter et al. EUROPEAN JOURNAL OF CANCER
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- Predictive and prognostic molecular markers for cancer medicine
- (2010) Sunali Mehta et al. Therapeutic Advances in Medical Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started